Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Louise Catherine Connell"'
Autor:
Vinod P. Balachandran, James J. Harding, Andrea Cercek, Michael I. D’Angelica, William R. Jarnagin, Louise Catherine Connell, Joshua S. Jolissaint, T. Peter Kingham, Kevin C. Soares, Kenneth Seier, Mithat Gonen, Nancy E. Kemeny, Ramyasree Madupuri, Ritika Kundra, Alice C. Wei, Thomas Boerner, Jeffrey A. Drebin, Carlie S. Sigel, Paul Shin, Efsevia Vakiani
Publikováno v:
Clin Cancer Res
Purpose: Lymph node metastasis (LNM) drastically reduces survival after resection of intrahepatic cholangiocarcinoma (IHC). Optimal treatment is ill defined, and it is unclear whether tumor mutational profiling can support treatment decisions. Experi
Autor:
William R. Jarnagin, Mithat Gonen, Louise Catherine Connell, Nancy E. Kemeny, Andrea Cercek, Constantinos P. Zambirinis, Jeffrey A. Drebin, Thomas Boerner, T.P. Kingham, Michael I. D’Angelica, Peter J. Allen, J. Gagnière, Joanne F. Chou, Vinod P. Balachandran
Publikováno v:
HPB (Oxford)
BACKGROUND: The utility of adjuvant chemotherapy after resection of colorectal liver metastasis (CLM) in patients with rapid recurrence after adjuvant chemotherapy for their primary tumor is unclear. The aim of this study was to evaluate the oncologi
Autor:
Kaitlin A. Tkachuk, Leonard B. Saltz, Neil H. Segal, Andrea Cercek, Kenneth Offit, Rona Yaeger, Michael F. Berger, Jinru Shia, Garrett M. Nash, Zalak Patel, Diane Reidy-Lagunes, Rania Sheikh, Jaclyn F. Hechtman, Zsofia K. Stadler, Louise Catherine Connell, Alicia Latham, Martin R. Weiser, Karuna Ganesh, Ahmet Zehir, Julio Garcia-Aguilar, David P. Kelsen, Diana Mandelker, Arnold J. Markowitz, Philip B. Paty, Nancy E. Kemeny
Publikováno v:
Clin Cancer Res
Purpose: The prevalence and clinical characteristics of small bowel adenocarcinomas (SBA) in the setting of Lynch syndrome have not been well studied. We characterized SBA according to DNA mismatch repair and/or microsatellite instability (MMR/MSI) a
Autor:
Louise Catherine Connell, Vinod P. Balachandran, Michael I. D’Angelica, Andrea Cercek, William R. Jarnagin, Peter Kingham, Bas Groot Koerkamp, Nancy E. Kemeny, Alice C. Wei, Susan L. Stewart, Peter J. Allen, Ronald P. DeMatteo, Sepideh Gholami, Jeffrey A. Drebin, Mithat Gonen
Publikováno v:
Ann Surg Oncol
Annals of Surgical Oncology, 28(7), 3685-3694. Springer New York
Annals of surgical oncology, vol 28, iss 7
Annals of Surgical Oncology, 28(7), 3685-3694. Springer New York
Annals of surgical oncology, vol 28, iss 7
BackgroundHepatic artery infusion (HAI) chemotherapy is associated with overall survival (OS) in patients with resected colon cancer liver metastases (CLM). The prognostic impact of primary tumor location in CLM following hepatic resection in patient
Autor:
J. Joshua Smith, Erin E. Salo-Mullen, Henry Walch, Diana Mandelker, Asha Krishnan, Michael F. Berger, Felix Steinruecke, Neil H. Segal, Gustavo Dos Santos Fernandes, Diane Reidy-Lagunes, Garrett M. Nash, Kimeisha Belanfanti, Leonard B. Saltz, Andrea Cercek, Zsofia K. Stadler, Karuna Ganesh, Anna M. Varghese, Chaitanya Bandlamudi, Mark E. Robson, Melissa Lumish, Jinru Shia, Vijai Joseph, Julio Garcia Aguilar, Nikolaus Schultz, Walid K. Chatila, Robin B. Mendelsohn, P. Paty, Kenneth Offit, Nancy E. Kemeny, Arnold J. Markowitz, Liying Zhang, Louise Catherine Connell, Preethi Srinivasan, Yelena Kemel, Barry S. Taylor, Ozge Birsoy, Jose G. Guillem, David B. Solit, Jesse Galle, Rona Yaeger, Sebastian Mondaca, Efsevia Vakiani, Luis A. Diaz, Anna Maio, Lerie Palmaira, Prince Rainier Tejada, Martin R. Weiser
Publikováno v:
J Natl Cancer Inst
Background The causative factors for the recent increase in early-onset colorectal cancer (EO-CRC) incidence are unknown. We sought to determine if early-onset disease is clinically or genomically distinct from average-onset colorectal cancer (AO-CRC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3723ce25fffa6cdb6d9d05fbf0a82091
https://europepmc.org/articles/PMC8634406/
https://europepmc.org/articles/PMC8634406/
Autor:
Andrea Cercek, Haley Hauser, William R. Jarnagin, Julio Garcia-Aguilar, Nikolaus Schultz, Jaclyn F. Hechtman, Louise Catherine Connell, Chao Wu, Michael I. D’Angelica, Walid K. Chatila, J. Joshua Smith, Isaac Wasserman, Christopher Madden, Rona Yaeger, Francisco Sanchez-Vega, Bryan C. Szeglin, Taryn M. Boucher, Nancy E. Kemeny, Jashodeep Datta, Azfar Basunia
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 8, Iss 15, Pp 6538-6548 (2019)
Cancer Medicine, Vol 8, Iss 15, Pp 6538-6548 (2019)
Background Resection of colorectal liver metastases (CLM) can cure disease, but many patients with extensive disease cannot be fully resected and others recur following surgery. Hepatic arterial infusion (HAI) chemotherapy can convert extensive liver
Autor:
Joanne F. Chou, Francisco Sanchez-Vega, Hongyu Shi, William R. Jarnagin, T.P. Kingham, Michael I. D’Angelica, Louise Catherine Connell, Nancy E. Kemeny, Walid K. Chatila, Marinela Capanu
Publikováno v:
Ann Surg
Objective/background The purpose was to determine whether adding Pmab versus no Pmab to an adjuvant regimen of hepatic arterial infusion (HAI) of floxuridine (FUDR) plus systemic (SYS) leucovorin, fluorouracil, and irinotecan (FOLFIRI) improves 15-mo
Autor:
Joanne F. Chou, Anna M. Varghese, Pallavi Vedantam, Andrea Cercek, Andreas Rimner, Karuna Ganesh, Travis J. Hollmann, Nancy E. Kemeny, Joseph P. Erinjeri, Yoshiya Yamada, Paul B. Romesser, Diane Reidy-Lagunes, Efsevia Vakiani, Aliya Holland, Neil H. Segal, T. Jonathan Yang, Geoffrey Y. Ku, Abraham J. Wu, Mark L. Solter, Martinique Ogle, Martin R. Weiser, Kathleen C. McAuliffe, Christopher H. Crane, Phillip Wong, Stephen B. Solomon, Danny N. Khalil, John J. Cuaron, Louise Catherine Connell, Marinela Capanu, Krishna Juluru, Taha Merghoub, Leonard B. Saltz, Zsofia K. Stadler, Rona Yaeger, Pamela Vaiskauskas, Ghassan K. Abou-Alfa, David Faleck, Matthew Adamow
Publikováno v:
Clin Cancer Res
Purpose:Immune checkpoint inhibition (ICI) alone is not active in mismatch repair–proficient (MMR-P) metastatic colorectal cancer (mCRC), nor does radiotherapy alone result in objective systemic benefit. However, combined radiotherapy plus ICI can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84496b65de242638490fa7cc0faf7d5e
https://europepmc.org/articles/PMC8499477/
https://europepmc.org/articles/PMC8499477/
Publikováno v:
Surg Oncol Clin N Am
Colorectal cancer (CRC) is one of the leading cancers globally in terms of both incidence and cancer-related mortality. Liver metastatic disease is the main prognostic driver for patients with CRC. The management options for liver metastatic CRC cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eac18e2ae1a4ca478d318e6f91f617d0
https://europepmc.org/articles/PMC8594481/
https://europepmc.org/articles/PMC8594481/
Publikováno v:
Colorectal Cancer Liver Metastases ISBN: 9783030254858
Colorectal cancer represents a significant global health burden, with the liver as the most common site of metastases. In patients with metastatic disease, 60% will develop liver metastases, and this is a major cause of morbidity and mortality. Histo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e69caa71af27b166090a3fddbc067b6
https://doi.org/10.1007/978-3-030-25486-5_22
https://doi.org/10.1007/978-3-030-25486-5_22